We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
-13.36%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$9.12B
AUM Growth
-$4.89B
Cap. Flow
-$2.96B
Cap. Flow %
-32.41%
Top 10 Hldgs %
31.89%
Holding
4,143
New
1,140
Increased
519
Reduced
655
Closed
1,293

Sector Composition

Rank Sector Weight
1 Technology 10.49%
2 Financials 8.55%
3 Energy 8.43%
4 Industrials 6.33%
5 Healthcare 5.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKYH.WS icon
2601
Sky Harbour Group Warrants
SKYH.WS
$21.4M
$21K ﹤0.01%
47,756
-34
-0.1% -$20
ALPP
2602
DELISTED
Alpine 4 Holdings Inc
ALPP
$21K ﹤0.01%
+3,818
New +$24.5K
EMAN
2603
DELISTED
eMagin Corporation
EMAN
$21K ﹤0.01%
+33,519
New +$27.5K
MKTWW
2604
DELISTED
MarketWise, Inc. Warrant
MKTWW
$21K ﹤0.01%
66,216
PSTH.WS
2605
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$21K ﹤0.01%
50,117
OTLK icon
2606
Outlook Therapeutics
OTLK
$191M
$20K ﹤0.01%
+1,006
New +$28.9K
SUNL.WS
2607
DELISTED
Sunlight Financial Holdings, Inc. Warrants, exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SUNL.WS
$20K ﹤0.01%
54,516
-4,467
-8% -$2.83K
HARP
2608
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$20K ﹤0.01%
+1,078
New +$27.9K
CMAXW
2609
DELISTED
CareMax, Inc. Warrant
CMAXW
$20K ﹤0.01%
31,053
-888
-3% -$1.05K
AEI icon
2610
Alset
AEI
$45.9M
$19K ﹤0.01%
+3,362
New +$27.6K
ALVOW icon
2611
Alvotech Warrant
ALVOW
$19K ﹤0.01%
+23,672
New +$21.4K
GALT icon
2612
Galectin Therapeutics
GALT
$348M
$19K ﹤0.01%
+14,817
New +$21.3K
VRCA icon
2613
Verrica Pharmaceuticals
VRCA
$87.3M
$19K ﹤0.01%
+1,015
New +$51K
YJ
2614
Yunji
YJ
$16.7M
$19K ﹤0.01%
+469
New +$19.7K
GBTG.WS
2615
DELISTED
Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
GBTG.WS
$19K ﹤0.01%
+18,740
New +$21.8K
ALJJ
2616
DELISTED
ALJ Regional Holdings Inc
ALJJ
$19K ﹤0.01%
10,251
-23,660
-70% -$52.8K
BXRX
2617
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$19K ﹤0.01%
+584
New +$27.3K
TIO
2618
DELISTED
Tingo Group, Inc. Common Stock
TIO
$19K ﹤0.01%
+34,166
New +$21.3K
BDSX icon
2619
Biodesix
BDSX
$248M
$18K ﹤0.01%
+550
New +$17.9K
CETX icon
2620
Cemtrex
CETX
$4.84M
0
MBAI
2621
Check-Cap
MBAI
$10.9M
$18K ﹤0.01%
+2,974
New +$21.2K
NNAVW
2622
DELISTED
NextNav Inc Warrant
NNAVW
$18K ﹤0.01%
43,940
RBOT.WS
2623
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$18K ﹤0.01%
60,195
-11,917
-17% -$6.68K
CLBTW
2624
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
$18K ﹤0.01%
24,427
-10,554
-30% -$9.63K
MTEM
2625
DELISTED
Molecular Templates, Inc.
MTEM
$18K ﹤0.01%
+1,379
New +$32.3K

Similar funds

HRT Financial's Q2 2022 Portfolio in Review

As of Q2 2022, HRT Financial held 4,143 positions worth $9.12B, down 35% from $14B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

HRT Financial withdrew a net $2.96B in Q2 2022, closing 1,293 positions and reducing 655 holdings. Its most notable exit was Oracle, an estimated $156M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Energy.

Against the trend, HRT Financial opened a new position in Valero Energy worth $133M.

  • HRT Financial's largest Q2 2022 buy was Valero Energy: 1,251,871 shares worth $133M.
  • HRT Financial added most to Marathon Petroleum in Q2 2022, an estimated $154M increase.
  • HRT Financial's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.33B.
  • HRT Financial fully exited Oracle in Q2 2022, selling an estimated $156M.
  • HRT Financial's ten largest holdings make up 32% of its $9.12B portfolio in Q2 2022.
  • HRT Financial opened 1,140 new positions and closed 1,293 in Q2 2022.
  • HRT Financial's portfolio value fell 35% quarter-over-quarter to $9.12B.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.